News &amp; Updates

Findings from the phase IV INHALE-3 trial support inhaled insulin for the management of type 1 diabetes (T1D) in adults, underlining its role as an alternative insulin solution to enhance diabetes management.

INHALE-3 underpins alternate insulin delivery method for T1D

17 Jul 2024

$Bisphosphonates cut fracture risk in older cirrhosis patients$

Bisphosphonates cut fracture risk in older cirrhosis patients

Older patients with cirrhosis who are taking bisphosphonates appear to have a reduced incidence of fractures overall, according to a study.

Bisphosphonates cut fracture risk in older cirrhosis patients

Non-communicable diseases affect low-income households disproportionately

Non-communicable diseases (NCDs) have the potential to significantly impact B40 households in a negative manner, reveals a local study.

Non-communicable diseases affect low-income households disproportionately

Red light therapy for eyesight improvement: A short overview

Red light therapy, sometimes referred to as photobiomodulation therapy or PBMT, has garnered significant interest because of its possible medical advantages, especially in the field of ophthalmology. Low-power red to near-infrared (NIR) light is used in PBMT to activate biological processes.

Red light therapy for eyesight improvement: A short overview

Novel HRS9531 shows promise as treatment for obesity in Chinese adults

Once-weekly treatment with HRS9531, a novel dual GLP-1* and GIP** receptor agonist, resulted in substantial reductions in body weight among Chinese patients with obesity, according to a study presented at ADA 2024.

Novel HRS9531 shows promise as treatment for obesity in Chinese adults

Original New Drug Application Approvals by US FDA (1-15 July 2024)

New drug applications approved by US FDA as of 1-15 July 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 July 2024)

Automated insulin delivery system beneficial for T2D management

16 Jul 2024 by

An automated insulin delivery (AID) system appears to improve clinical outcomes in people with type 2 diabetes (T2D), with the pivotal SECURE-T2D trial showing substantial improvements in glycated haemoglobin, total daily insulin dose, and diabetes distress, without increasing the risk of hypoglycaemia.

Automated insulin delivery system beneficial for T2D management

16 Jul 2024

Breastfeeding may prevent development of JSpA in infants

Infant factors affecting the microbiome appears to influence the occurrence of juvenile spondyloarthritis (JSpA), suggests a study, noting a link between exclusive breastfeeding and lower odds of JSpA.

Breastfeeding may prevent development of JSpA in infants

Eating more fibre-rich foods, less red meat and sugar may prolong life expectancy

16 Jul 2024 by

Changing your usual eating pattern to one that is focused on longevity can bring substantial increases in life expectancy (LE), suggests a study that involved seven countries. These dietary changes include more whole grains, legumes, and nuts and less red/processed meats, sugars, and sugar-sweetened beverages.

Eating more fibre-rich foods, less red meat and sugar may prolong life expectancy

Weight gain tied to hypertension in patients on methadone maintenance treatment